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In vertebrates, unfertilized eggs are arrested atmeta-
phase of meiosis II by Mos and Emi2, an inhibitor of
the APC/C ubiquitin ligase. In Xenopus, Cdk1 phos-
phorylates Emi2 and both destabilizes and inacti-
vates it, whereas Mos recruits PP2A phosphatase
to antagonize the Cdk1 phosphorylation. However,
how Cdk1 phosphorylation inhibits Emi2 is largely
unknown. Here we show that multiple N-terminal
Cdk1 phosphorylation motifs bind cyclin B1-Cdk1
itself, Plk1, and CK1d/ε to inhibit Emi2. Plk1, after
rebinding to other sites by self-priming phosphoryla-
tion, partially destabilizes Emi2. Cdk1 and CK1d/ε
sequentially phosphorylate the C-terminal APC/C-
docking site, thereby cooperatively inhibiting Emi2
from binding the APC/C. In the presence of Mos,
however, PP2A-B56b/ε bind to Emi2 and keep de-
phosphorylating it, particularly at the APC/C-docking
site. Thus, Emi2 stability and activity are dynamically
regulated by Emi2-bound multiple kinases and PP2A
phosphatase. Our data also suggest a general role
for Cdk1 substrate phosphorylation motifs in M
phase regulation.
INTRODUCTION
The cyclin-dependent kinase 1 (Cdk1) associated with cyclin B
plays a central role in M phase of the mitotic cell cycle (Enserink
and Kolodner, 2010). The meiotic cell cycle consists of two
successive divisions, meiosis I and meiosis II, which are also
driven by cyclin B-Cdk1 (Marston and Amon, 2004). In verte-
brates, mature oocytes (or unfertilized eggs) are arrested at
metaphase of meiosis II, or Meta-II, to await fertilization (Sagata,
1996). This arrest is caused by a cytoplasmic activity called cyto-
static factor (CSF) (Masui and Markert, 1971). CSF inhibits the
anaphase-promoting complex/cyclosome (APC/C), a multisub-506 Developmental Cell 21, 506–519, September 13, 2011 ª2011 Elsunit E3 ubiquitin ligase (Peters, 2006), thereby preventing cyclin
B degradation and exit from Meta-II (Tunquist and Maller, 2003).
CSF consists mainly of the classical Mos-MAPK pathway (Kishi-
moto, 2003; Nebreda and Ferby, 2000; Sagata, 1996; Tunquist
and Maller, 2003) and Emi2 (also called Erp1), a direct inhibitor
of the APC/C (Schmidt et al., 2005; Shoji et al., 2006; Tung
et al., 2005). Both Mos and Emi2 are synthesized during oocyte
maturation and degraded upon fertilization, although Emi2 is
resynthesized shortly after fertilization (Liu et al., 2006; Madg-
wick et al., 2006; Ohe et al., 2007; Sagata et al., 1989; Schmidt
et al., 2005).
Emi2 protein consists of an N-terminal regulatory region and
a C-terminal functional region. The C-terminal region contains
a destruction box (D-box), which likely competes with APC/C
substrates (including cyclin B) for APC/C binding, and a zinc-
binding region (ZBR), which somehow inhibits APC/C ubiquitin
ligase activity (Miller et al., 2006; Schmidt et al., 2005). In addi-
tion, the well-conserved C-terminal tail, termed the RL tail,
serves as a docking site for the APC/C, promoting the inhibitory
interactions of the D-box and the ZBRwith the APC/C (Ohe et al.,
2010). In contrast to these, the N-terminal region possesses
signals required for rapid Emi2 degradation upon fertilization,
including a calmodulin-dependent protein kinase II (CaMKII)
phosphorylation site and a DSG destruction motif recognized
by SCFb-TrCP ubiquitin ligase (Hansen et al., 2006; Liu andMaller,
2005; Rauh et al., 2005).
In Xenopus oocytes, the Mos-MAPK pathway upregulates
both the stability and activity of Emi2, thus promoting Meta-II
arrest (Inoue et al., 2007; Nishiyama et al., 2007). Rsk, the kinase
immediately downstream from MAPK (or ERK2), directly phos-
phorylates Emi2 at residues in the central region (Inoue et al.,
2007), and thereby recruits the protein phosphatase PP2A to
Emi2 (J.Q. Wu et al., 2007; Q. Wu et al., 2007). Recruited PP2A
likely antagonizes Emi2 N-terminal and C-terminal phosphoryla-
tions by Cdk1, which have been suggested to destabilize and
inactivate Emi2, respectively (Hansen et al., 2007; J.Q. Wu
et al., 2007). However, how Cdk1-mediated phosphorylation
both destabilizes and inactivates Emi2 is largely unknown,
although this issue is crucial for understanding the mechanism
of Emi2 upregulation by the Mos-MAPK pathway.evier Inc.
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Figure 1. Requirement of N-Terminal Cdk1 Sites for Inactivation of Emi2
(A) A recently proposed model for regulation of Emi2 stability and activity (Hansen et al., 2007; J.Q. Wu et al., 2007; Q. Wu et al., 2007). For details, see text. The
Ser/Thr residues in the M region are hitherto uncharacterized Cdk1 motifs.
(B) Schematic representation of Emi2 constructs used in (C–F). Ala mutations in the DSG and DSA motifs are S33/38A and S275/279A, respectively.
(C) (Myc3-tagged) sEmi2 constructs were expressed in CSF extracts (by adding their mRNAs), immunoprecipitated (IP), treated with l phosphatase (+ l), and
immunoblotted (IB). In the bar diagram, the levels of coprecipitated Cdc27 were quantified and normalized to sEmi2 constructs; the relative values to Cdc27
coprecipitated with sEmi2(2A) are shown (mean ± SD, n = 4).
(D) CSF extracts expressing sEmi2 constructs as in (C) were treated with cycloheximide for 5 min, treated with calcium, collected at the indicated times, treated
with l phosphatase, and immunoblotted. The asterisk shows endogenous Emi2 (which is degraded upon calcium treatment).
(E) Two-cell embryoswere injected (at their one blastomere) with 460 pg ofmRNA encoding the indicated (Myc3-tagged) sEmi2 constructs, cultured for 2.5 hr, and
photographed. To detect Emi2 and cyclin B2, one-cell embryos were injected with 920 pg of the respective mRNAs, cultured for 3 hr, and subjected to
immunoblotting (after l phosphatase treatment). Asterisk, endogenous Emi2.
(F) CSF extracts expressing the indicated (Myc3-tagged) (s)Emi2 constructs were analyzed as in (C).
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Regulation of Emi2 Stability and ActivityHere, we have explored the mechanisms of Emi2 inhibition
by Cdk1 (as well as Emi2 upregulation by Mos) using Xenopus
egg extracts. Our results show that multiple distinct kinases,
including cyclin B1-Cdk1 itself, bind to the N-terminal Cdk1 sites
of Emi2 and phosphorylate other critical sites to destabilize and
inactivate Emi2. Mos/Rsk-recruited PP2A, identified here as
PP2A-B56b/ε, keeps preferentially dephosphorylating the crit-
ical inhibitory sites of Emi2. Thus, Emi2 stability and activity are
dynamically regulated by Emi2-bound multiple kinases and
PP2A phosphatase, providing new insight into the mechanisms
of Emi2 regulation in Meta-II arrest of vertebrate eggs. In addi-Developmention, our data seem to provide general implications for Cdk1
substrate phosphorylation motifs in M phase regulation.
RESULTS
Multiple N-Terminal Phosphorylations by Cdk1 Not Only
Destabilize but Also Inactivate Emi2
By using fragments of Emi2, it has been suggested that
N-terminal Cdk1 phosphorylation at four Ser/Thr-Pro motifs
(S213/T239/T252/T267 in the N region; Figure 1A) partially
destabilizes Emi2 by a mechanism involving SCFb-TrCP, whereastal Cell 21, 506–519, September 13, 2011 ª2011 Elsevier Inc. 507
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Regulation of Emi2 Stability and ActivityC-terminal Cdk1 phosphorylation at two Thr-Pro motifs (T545/
551) inactivates Emi2 by inhibiting the interaction with the
APC/C (Hansen et al., 2007; J.Q. Wu et al., 2007; Q. Wu et al.,
2007). The Mos-MAPK-Rsk pathway phosphorylates Emi2 at
S335/T336 and thereby recruits PP2A, which likely antagonizes
both the N-terminal and C-terminal inhibitory phosphorylations
by Cdk1 (J.Q. Wu et al., 2007) (Figure 1A). To confirm the
above-mentioned results (obtained with Emi2 fragments) with
full-length Emi2, we used a full-length, Rsk-nonphosphorylat-
able S335/T336/Ala (2A) mutant of Emi2, termed here
Emi2(2A) (see Figure 1B), to circumvent the Mos/Rsk effects
on Emi2 (Inoue et al., 2007). Consistent with the previous
proposal (J.Q. Wu et al., 2007), the N-terminal phosphorylation
was required for partial destabilization of full-length Emi2(2A) in
Meta-II egg extracts (or CSF extracts) (see Figure 3D). We then
asked whether the C-terminal phosphorylation (at T545/551)
was required for inactivation of Emi2(2A). For this, we compared
the APC/C-binding activities of Emi2(2A) and Emi2(2A/C2A), in
which the C-terminal T545/551 (C2) residues, together with
S335/T336, were mutated to Ala (Figure 1B). In this and most
other experiments, various Emi2 constructs (tagged with Myc-
epitopes) were all in an SCFb-TrCP-resistant, stable form (with
mutations in the DSG/DSA degradation motifs), termed here
sEmi2 (see Figure 1B), for their activities to be compared prop-
erly. When expressed in CSF extracts (by adding their mRNAs)
and immunoprecipitated, sEmi2(2A/C2A) was bound to the
(endogenous) APC/C core subunit Cdc27 2.5-fold more
strongly than sEmi2(2A), but, notably, much (3-fold) less
strongly than sEmi2(WT) (Figure 1C). Thus, the C-terminal phos-
phorylation is likely required for inactivation of full-length Emi2 as
proposed (Hansen et al., 2007; J.Q. Wu et al., 2007; Q. Wu et al.,
2007), but it is so only partially.
Given this unanticipated result, we next addressed whether
N-terminal phosphorylation would be required for Emi2 inactiva-
tion (besides Emi2 destabilization). In CSF extracts, sEmi2(2A/
N4A), in which the four N-terminal Cdk1 sites (N4: S213/T239/
252/267 in the N region) were mutated to Ala (Figure 1B), bound
Cdc27 2-fold more strongly even than sEmi2(2A/C2A), but
1.5-fold less strongly than sEmi2(WT) (Figure 1C). Interestingly,
sEmi2(2A/M4A), in which another N-terminal cluster of four
previously uncharacterized Cdk1 S/TP motifs (M4: S43/73/T97/
S157 in the M region; Figure 1A) was mutated to Ala (Figure 1B),
gave fairly similar results to those of sEmi2(2A/N4A) (Figure 1C).
sEmi2(2A/M4A) also showed smaller phosphatase-sensitive
mobility shifts than sEmi2(2A) (Figure 1C), indicating phosphory-
lation of the S/TPmotifs in theM region. Furthermore, and impor-
tantly, sEmi2(2A/MN8A), in which the N4A and M4A mutations
were combined (Figure 1B), showed little mobility shifts, and
bound the APC/C slightly more strongly even than sEmi2(WT),
or 4-fold and 10-fold more strongly than sEmi2(2A/C2A)
and sEmi2(2A), respectively (Figure 1C). Thus, the MN8A
mutation, unlike the C2A mutation, can fully restore the APC/
C-binding (and hence probably APC/C-inhibitory) activity of
sEmi2(2A) to that of sEmi2(WT). Indeed, sEmi2(2A/MN8A) was
able to inhibit cyclin B degradation (or APC/C activity) much
more strongly than sEmi2(2A/C2A), upon calcium-induced CSF
release (which mimics fertilization) (Schmidt et al., 2005) (Fig-
ure 1D). Furthermore, when expressed at endogenous levels in
2-cell embryos (Sagata et al., 1989), sEmi2(2A/MN8A), but not508 Developmental Cell 21, 506–519, September 13, 2011 ª2011 ElssEmi2(2A/C2A), could cause cleavage arrest with accumulated
cyclin B (Figure 1E). Thus, surprisingly, in the context of full-
length Emi2, the N-terminal phosphorylation is much more crit-
ical for Emi2 inactivation than the C-terminal phosphorylation.
The N-terminal phosphorylation may negatively impact the
C-terminal half of Emi2 (containing the D-box, the ZBR, and
the RL tail; Figure 1A), because this region functions to bind
and inhibit the APC/C (Ohe et al., 2010; Schmidt et al., 2005;
J.Q. Wu et al., 2007). Consistently, the high APC/C-binding
activity of sEmi2(2A/MN8A) was comparable to that of the
C-terminal fragment of Emi2 (residues 351–651; see Figure 1B)
(Figure 1F). Thus, the N-terminal phosphorylation likely inacti-
vates full-length Emi2 by negatively impacting the APC/C-
binding ability of the C-terminal region.
Cyclin B1-Cdk1 and Plk1 Bind to the N-Terminal Cdk1
Sites of Emi2
Howmight the N-terminal phosphorylation negatively impact the
C-terminal APC/C-binding activity (as well as the stability) of
Emi2? Several possibilities tested, such as an inhibitory binding
of the N-terminal phospho-region to the C-terminal region and
a conformational change of Emi2 by the phospho-S/TP-directed
prolyl isomerase Pin1, were negative. Then we addressed
whether any inhibitory factor(s) could bind to the N-terminal
phospho-region to affect Emi2 activity and stability. Interest-
ingly, our initial study by mass spectrometry showed that
cyclin B1-Cdk1 and Polo-like kinase 1 (Plk1; Plx1 in Xenopus)
bind to the N-terminal fragment (1–300) of Emi2 in CSF extracts.
To analyze this result in more detail, we expressed various
Emi2 constructs in CSF extracts. When immunoprecipitated,
sEmi2(2A) was bound to both cyclin B1-Cdk1 and Plk1 signifi-
cantly (2-fold) more strongly than sEmi2(WT) (Figure 2A).
(About 90% of total sEmi2(2A) proteins were estimated to be
bound to cyclin B1-Cdk1; see Figure S1A available online.)
Importantly, these bindings were greatly impaired by the
N-terminal MN8A mutation, partially impaired either by the M4A
or the N4A mutations, but not impaired at all by the C-terminal
C2A mutation (Figure 2A). Furthermore, such bindings were
observed only with the Emi2 N-terminal (1–350, containing only
the 2A mutation) but not C-terminal (351-651) fragments in a
Cdk1 inhibitor roscovitine-sensitive manner (Figure 2B). Thus,
clearly, the N-terminal Cdk1 phosphorylation (both in the M
and N regions) acts to promote the binding of cyclin B1-Cdk1
and Plk1 to Emi2.
Because cyclin B-Cdk1 itself can bind to Cdk1 phosphoryla-
tion sites (S/TP motifs) in a certain protein (Mimura et al.,
2004), we hypothesized that cyclin B1-Cdk1 (and possibly also
Plk1) might bind to the N-terminal Cdk1 S/TP sites of Emi2. To
test this intriguing possibility, we incubated synthetic phospho-
peptides, from the Emi2 N region and coupled to beads, with
CSF extracts, and subjected them to pulldown assays. Among
the four phospho(p)-peptides (containing pS213, pT239,
pT252, or pT267; see Supplemental Experimental Procedures),
pT267-peptides and, to a lesser extent, pT252- and pT239-
peptides could bind cyclin B1-Cdk1, whereas pS213- and
pT267-peptides bound Plk1; none of their nonphosphorylated
peptides could do so (Figure 2C). (One or two phospho-peptides
from the Emi2M region could also bind cyclin B1-Cdk1 and Plk1;
Figure S1B.) Similar bindings to the phospho-peptides were alsoevier Inc.
IB: Plk
IB: CycB1
IB: Cdk1
Myc-IP (+λ)
(-)
W
T
2A 2A
/N
4A
2A
/C
2A
2A
/M
4A
2A
/M
N8
A
Input
(-)
W
T
2A 2A
/N
4A
2A
/C
2A
2A
/M
4A
2A
/M
N8
A
IB: Myc 
 (Emi2) IB: Myc
 (Emi2)
IB: Plk
IB: CycB1
IB: Cdk1
(-)
2A 2A
/M
N8
A
35
1-
65
1
1-350
(-)
2A 2A
/M
N8
A
35
1-
65
1
1-350
DMSO Rosco.
Myc-IP
IB: Cdk1
IB: CycB1
IB: Plk
In
pu
t
pS
21
3
pT
23
9
pT
25
2
pT
26
7
S2
13
T2
67
P-peptideNon-p-peptide
Bead-PD
T2
39
T2
52
IB: Flag
   (Plk)
W
T
PB
-m
u
WT PB-mu
(-) S2
13
pS
21
3
T2
67
pT
26
7
(-) S2
13
pS
21
3
T2
67
pT
26
7
Input
Bead-PD
IB: Cdk1
IB: CycB1
IB: Plk
In
pu
t
pT
26
7
T2
67
Bead-PD
pT
26
7/
P2
68
A
A B
C D
E
Figure 2. Binding of Cyclin B1-Cdk1 and Plk1 to the N-Terminal Cdk1 Sites
(A and B) (Myc3-tagged) (s)Emi2 constructs expressed in CSF extracts were immunoprecipitated, treated (A) or not treated (B) with l phosphatase, and
immunoblotted. In (B), CSF extracts were treated with control DMSO or 300 mM roscovitine (Rosco.) for 30 min before immunoprecipitation.
(C–E) The indicated peptides coupled to beads were incubated with CSF extracts expressing no Plk1 constructs (C and D) or expressing (Flag-tagged) WT Plk1
or PB-mutated (mu; H532A/K534M) Plk1 (E), pulled down, and immunoblotted.
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Regulation of Emi2 Stability and Activityobserved in vitro with (human) recombinant cyclin B1-Cdk1 and
Plk1 proteins (but not control MAPK or PKC proteins) (Fig-
ure S1C). Furthermore, pT267/P268A-peptides, unlike WT
pT267-peptides, failed to strongly bind cyclin B1-Cdk1 and
Plk1 in CSF extracts (Figure 2D), indicating the importance of
the +1 position of Pro in the bindings. Thus, together with the
above results (Figures 2A and 2B), these data strongly suggest
that cyclin B1-Cdk1 and Plk1 bind directly and specifically to
the partially overlapping N-terminal Cdk1 sites of Emi2.
Our finding that Plk1 can bind to the simple Cdk1 phosphory-
lation sites (pS/pTP, not preceded by Ser; see Supplemental
Experimental Procedures) of Emi2 is surprising, because this
kinase has been shown to bind primarily to SpS/pT(P/X) motifs
in a polo-box (PB) domain-dependent manner (Elia et al.,
2003). However, both pS213- and pT267-peptides were able
to bind even PB-mutated Plk1 (H532A/K534M; Elia et al., 2003)
in CSF extracts (Figure 2E). Thus, it appears that Plk1 can bind
to the N-terminal Cdk1 sites in a PB-independent manner.
Plk1 Rebinds to Other Sites by Self-Priming
Phosphorylation and Destabilizes Emi2
We first addressed the role of N-terminally bound Plk1 in Emi2
regulation. Because Plk1 could bind to the Emi2 N-terminal
phospho-peptides in a PB-independent manner (Figure 2E), first
we asked whether its binding to full-length sEmi2(2A) would also
be PB-independent. Strikingly, however, PB-mutated Plk1
bound to sEmi2(2A) much less efficiently than WT Plk1 (Fig-
ure 3A), indicating that Plk1 binding to full-length Emi2 is largelyDevelopmenPB-dependent. The N-terminal half of Emi2 (to which Plk1 binds;
Figure 2B) contains three potential PB-binding sites (SpS/pT) at
T170, T195, and S222. Interestingly, Ala mutation of these sites
revealed that both T170 and T195, but not S222, were required
for Plk1 binding of sEmi2(2A) (if not to the same extent as the
N-terminal Cdk1 sites) (Figure 3B). T195 of sEmi2(2A) was phos-
phorylated in CSF extracts, albeit modestly (Figure S2A; see also
Figure 3F). Thus, these results suggest that in (full-length) Emi2,
Plk1 binds principally to phospho-T170/195 sites in a PB-depen-
dent manner.
Emi2(2A) (and, to a lesser extent, Emi2(WT)) is slowly
degraded in mature oocytes and CSF extracts in a manner
dependent on the N-terminal Cdk1 sites and the SCFb-TrCP-
recognizing phospho-DSGmotif (as well as its related DSAmotif)
(Inoue et al., 2007; Nishiyama et al., 2007; J.Q. Wu et al., 2007).
(Accordingly, the stable sEmi2 constructs routinely used in this
study contained mutations both in the DSG and the DSA motifs;
Figure 1B.) Because Plk1 can phosphorylate the DSG motif of
Emi2 (Schmidt et al., 2005) (see also Figure 3G), as well as the
DSA motif (Figure 3C), Plk1 bound to pT170/195 could be
responsible for the instability of Emi2(2A). Indeed, in vitro trans-
lated (and 35S-labeled) Emi2(2A) was stabilized in CSF extracts
treated with the Plk1 inhibitor BI2536, and Emi2(2A/T170/195A)
was nearly as stable as sEmi2(2A) and Emi2(2A/MN8A) (Fig-
ure 3D). Thus, most probably, Plk1 bound to pT170/195
acts to destabilize Emi2(2A) through phosphorylating the DSG/
DSA motifs. Plk1 targets Emi2 for very rapid degradation upon
calcium-induced CSF release (Schmidt et al., 2005), wheretal Cell 21, 506–519, September 13, 2011 ª2011 Elsevier Inc. 509
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Figure 3. Rebinding and Destabilization of Emi2 by Plk1
(A) CSF extracts expressing (Myc3-tagged) sEmi2(2A) and either (Flag-tagged) WT Plk1 or PB-mutated (mu) Plk1 were subjected to Myc immunoprecipitation
followed by l phosphatase treatment and immunoblotting.
(B) (Myc3-tagged) sEmi2 constructs expressed in CSF extracts were immunoprecipitated, treated with l phosphatase, and immunoblotted.
(C) The indicated GST-Emi2 (DSA) peptide fusion proteins (with or without Ser/Ala mutations) were subjected to in vitro kinase assays using [g-32P]ATP and
Plk1, followed by SDS/PAGE, Coomassie brilliant blue staining (CBB), and autoradiography (32P).
(D) In vitro translated and 35S-labeled (s)Emi2 constructs were incubated with CSF extracts in the presence of DMSO () or 10 mM BI2536, treated with l
phosphatase, and subjected to SDS/PAGE followed by autoradiography.
(E) (Myc3-tagged) sEmi2 constructs expressed in CSF extracts were immunoprecipitated and then immunoblotted with phospho-specific (anti-pT195) and other
antibodies.
(F) CSF extracts were treated with control DMSO, 10 mMBI2536, or 300 mM roscovitine for 15min, incubated with in vitro synthesized/immunoprecipitated (Myc3-
tagged) sEmi2(2A) protein, and subjected to pulldown followed by immunoblotting.
(G) In vitro kinase assays of the indicated GST-Emi2 peptide fusion proteins were performed as in (C). The DSGmotif peptide and the N-terminal Cdk1 site (T267)
peptide served as positive controls for Plk1 and Cdk1, respectively.
(H) The indicated peptides coupled to beads were analyzed as in Figure 2C.
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Regulation of Emi2 Stability and Activityboth T195 phosphorylation and Plk1 binding of Emi2 occur
(Hansen et al., 2006; Schmidt et al., 2005), but much more
strongly than during CSF arrest (Figure S2A). Thus, during CSF
arrest, moderate Plk1 binding to pT170/195 probably is respon-
sible for the slow degradation of Emi2(2A).
We then asked what kinase(s) would phosphorylate T170/195
of sEmi2(2A). CaMKII, the kinase responsible for T195 phosphor-
ylation upon calcium-induced CSF release (Liu andMaller, 2005;
Rauh et al., 2005), was apparently not involved in T195 phos-
phorylation of sEmi2(2A) during CSF arrest (data not shown).
Interestingly, however, during CSF arrest, T195 phosphorylation
(as well as Plk1 binding) was greatly reduced in sEmi2(2A/MN8A)
and significantly reduced even in sEmi2(2A/S213A) (Figure 3E),
raising the possibility that either N-terminal Cdk1 site-bound
Cdk1 or, more likely, Plk1 (see Figure 2C) phosphorylates T195510 Developmental Cell 21, 506–519, September 13, 2011 ª2011 Elsof sEmi2(2A). Treating CSF extracts with either roscovitine
(which inhibits both Cdk1 and Plk1 bindings to the N-terminal
Cdk1 sites; Figure 2B) or BI2536 prevented T195 phosphoryla-
tion of sEmi2(2A) (Figure 3F). Importantly, however, only Plk1
but not Cdk1 could phosphorylate T195 (as well as T170) of
glutathione S-transferase (GST)-fused Emi2 peptides in vitro,
albeit less strongly than the DSG motif (Figure 3G). Plk1 could
also phosphorylate T195 of full-length Emi2 in vitro, though
weakly (Figure S2B). Thus, Plk1 bound to N-terminal Cdk1 sites
(mainly pS213 and pT267; Figure 2C) seems to phosphorylate
T170/195 of sEmi2(2A), although such Plk1-Cdk1 site binding
was not necessarily obvious in sEmi2(2A) (see 2A/T170/195A in
Figure 3B), probably due to it being much weaker than the Plk1
binding to pT170/195 sites (Figure 3H). Indeed, in vitro, prior
phosphorylation of Emi2 by Cdk1 could cause Plk1 binding toevier Inc.
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Regulation of Emi2 Stability and Activitythe N-terminal Cdk1 sites (albeit weakly), and thereby could
substantially increase T170/195 phosphorylation and binding
by Plk1 (Figure S2B).
Collectively, these results indicate that Plk1 first binds to
the N-terminal Cdk1 sites, phosphorylates, and creates its own
(PB-dependent) stronger binding sites at, T170/195, and then
phosphorylates the DSG/DSA motifs to destabilize Emi2(2A),
explaining the dependency of Emi2(2A)’s instability on the
N-terminal Cdk1 sites (Figure 3D) (J.Q. Wu et al., 2007).
Emi2-Bound Cdk1 Phosphorylates the RL Tail
as Well as the C-Terminal Cdk1 Sites
We next addressed the role of N-terminally bound cyclin B1-
Cdk1 in Emi2 regulation. For this, first we asked whether
N-terminal phosphorylation (hence Cdk1 binding) would be
required for the phosphorylation of the C-terminal Cdk1 sites,
or T545/551 (to which Cdk1 did not bind; Figure 2A). When ex-
pressed in CSF extracts, sEmi2(2A/MN8A) was phosphorylated
at T545 much (70%) less efficiently than sEmi2(2A) (Figure 4A).
The C-terminal fragment (351-651) of Emi2 was similarly less
phosphorylated at T545 than sEmi2(2A) (Figure 4A). Because
neither sEmi2(2A/MN8A) nor the C-terminal fragment, unlike
sEmi2(2A), can bind Cdk1 (Figures 2A and 2B), these results
suggest that the N-terminally bound Cdk1 contributes largely
to the phosphorylation of T545/551, thereby probably inhibiting
sEmi2(2A) activity at least partially (Figure 1) (Hansen et al.,
2007; Q. Wu et al., 2007).
In fact, the N-terminal phosphorylation had a much greater
inhibitory effect on Emi2 activity than the C-terminal T545/551
phosphorylation (Figure 1). Therefore, the N-terminally bound
Cdk1 (or possibly Plk1) could phosphorylate some additional
site(s) (besides T545/551) in Emi2, perhaps also in the C-terminal
region (Figure 1F), to inhibit Emi2 activitymoregreatly.Onecandi-
date target for this phosphorylation is the C-terminal tail, termed
the RL tail, which we have recently identified as an APC/C-dock-
ing site of Emi2 (Ohe et al., 2010). The RL tail consists of 10
amino acids and contains two conserved Ser residues (641/
644), which, together with several other residues including the
ultimate Arg-Leu (RL) residues, are essential for APC/C binding
of Emi2 (Ohe et al., 2010) (Figure 4B). Using phospho-specific
antibodies, we first determined whether S641/644 would be
phosphorylated in sEmi2(2A) or other Emi2 constructs in CSF
extracts. Intriguingly, S641 and S644 were both significantly
phosphorylated in sEmi2(2A); notably, however, they were much
less (30% and 10%, respectively) phosphorylated in either
sEmi2(2A/MN8A) or the C-terminal fragment (351-651) of Emi2
(Figure 4C). Thus, N-terminally bound Cdk1 or Plk1 is likely to
be required for S641/644phosphorylation. To confirm this further,
we askedwhether an N-terminal region (containing only the Cdk1
phosphorylation sites) alone would be sufficient for S641/644
phosphorylation. When connected to GST-RL tail fusion protein,
an sEmi2 N-terminal (1-300) WT fragment, but not a correspond-
ing MN8A fragment, could confer strong phosphorylation on
S641/644 (Figure 4D), just as in nonchimeric sEmi2 constructs
(Figure 4C). As expected (Figure 2B), the chimeric construct con-
taining the WT but not the MN8A fragment was associated with
both Cdk1 and Plk1 (Figure 4D). Thus, these results strongly sug-
gest that the N-terminally bound Cdk1 or Plk1 (or possibly yet
another bound kinase) phosphorylates S641/644 of the RL tail.DevelopmenWe addressed which kinase, Cdk1 or Plk1, would be respon-
sible for S641/644 phosphorylation. Treating CSF extracts with
roscovitine but not BI2536 greatly reduced the phosphorylation
of both S641 and S644 in sEmi2(2A) (Figure 4E). Furthermore,
and notably, in vitro kinase assays using RL tail peptides
(fused to GST) and [g-32P]ATP showed that Cdk1, but not Plk1,
could phosphorylate S641 but not S644 very strongly (to the
same extent as T545/T551) (Figure 4F). Essentially the same
results were obtained by in vitro kinase assays using full-length
Emi2 protein and phospho-specific antibodies (Figure 4G).
Somewhat curiously, S641 does not lie in the Cdk1 consensus
motif or S/TP (Figure 4B), but nonconsensusmotifs can be phos-
phorylated by Cdk1 in other proteins as well (Harvey et al., 2005;
McCusker et al., 2007). Altogether, these results strongly indi-
cate that the N-terminally bound Cdk1 phosphorylates S641 of
the RL tail, in addition to the C-terminal Cdk1 sites (T545/551).
CK1d/ε Bind to Emi2 and Phosphorylate S644,
Both in a Cdk1-Dependent Manner
Unlike S641, S644 of the RL tail was not phosphorylated byCdk1
in vitro (Figures 4F and 4G). In CSF extracts, however, S644
phosphorylation was dependent on Cdk1 activity, similar to
S641 phosphorylation (Figure 4E). Given these results and the
close location of S644 to S641, S644 phosphorylation (by some
kinase) might require a prior S641 phosphorylation by Cdk1. In
this respect, we noticed that S644 lies in the casein kinase 1
(CK1) consensus motif (pS/pT-X-X-S/T) as S641 is phosphory-
lated. Upon treatment of CSF extracts with either the pan-CK1
inhibitor D4476 or theCK1d/ε-specific inhibitor IC261, phosphor-
ylation of S644 in sEmi2(2A) was largely impaired, whereas that
of S641 (and T545) was not (Figure 4H). Furthermore, CK1(d)
was able to strongly phosphorylate S644 of Emi2 protein
in vitro, but only in the presence of Cdk1 (which phosphorylated
S641) (Figure 4I). Thus, evidently, CK1 phosphorylates S644 after
the priming S641-phosphorylation by Cdk1.
Given its ability to target Emi2 as a substrate, CK1 might bind
to Emi2 to efficiently phosphorylate it. Indeed, when ectopically
expressed in CSF extracts, CK1ε (as well as CK1a and CK1d;
data not shown) was bound to sEmi2(2A) (Figure 4J). Surpris-
ingly, such binding was observed with the N-terminal fragment
(1-350) of sEmi2(2A) but not with its C-terminal fragment (351-
651) or with sEmi2(2A/MN8A) (Figure 4J), suggesting that
CK1 binds to the N-terminal Cdk1 sites. Indeed, CK1(ε) was
able to bind to the N-terminal phospho-peptides (mainly
pT239/267) in CSF extracts (Figure 4K), as well as in vitro (Fig-
ure S3A). Mass spectrometry analysis revealed the association
of pT267-peptides with endogenous CK1d and CK1ε proteins
(Figure S3B), consistent with the CK1d/ε-specific inhibitor
IC261 having affected S644 phosphorylation in CSF extracts
(Figure 4H). Thus, unexpectedly, CK1 (at least d and ε isoforms),
like Cdk1 and Plk1 (Figure 2), can bind to the (partially overlap-
ping) N-terminal Cdk1 sites of Emi2. Altogether, these results
strongly suggest that N-terminally bound CK1d/ε phosphorylate
S644 of the RL tail.
Phosphorylation of the RL Tail Inhibits Emi2
from Binding the APC/C
We addressed whether phosphorylation of S641/644 (by Cdk1/
CK1) could affect the ability of the RL tail to bind the APC/C.tal Cell 21, 506–519, September 13, 2011 ª2011 Elsevier Inc. 511
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Figure 4. Sequential Phosphorylation of the RL Tail by Cdk1 and CK1
(A) (Myc3-tagged) (s)Emi2 constructs expressed in CSF extracts were immunoprecipitated and then immunoblotted with anti-Myc and anti-phospho-T545
antibodies. In the bar diagram, the levels of each pT545-signal were quantified and normalized to each (s)Emi2 construct; the relative values to the pT545-signal of
sEmi2(2A) are shown (mean ± SD, n = 4).
(B) Alignment of the RL tails of Emi2 proteins from various species. Dotted residues are those essential for APC/C binding (Ohe et al., 2010).
(C) Performed and analyzed as in (A) using the indicated phospho-specific antibodies (mean ± SD, n = 4).
(D) (Myc3-tagged) sEmi2 N-terminus(1-300;WT or MN8A)-GST-RL tail(629-651) fusion constructs, as well as a (Myc3-tagged) GST-RL tail construct, were
expressed in CSF extracts and analyzed as in (C) (mean ± SD, n = 3); immunoblotting was also performed for Plk1, cyclin B1, and Cdk1.
(E) Pulldown and immunoblotting of (Myc3-tagged) sEmi2(2A), performed as in Figure 3F.
(F) In vitro kinase assays of GST-RL tail fusion proteins, performed as in Figure 3G.
(G) In vitro translated (Myc3-tagged) sEmi2(WT) protein was immunoprecipitated, phosphorylated by the indicated kinases, and immunoblotted.
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Regulation of Emi2 Stability and ActivityTo do this, we used synthetic RL tail peptides (638-651), which
contained pS641 and/or pS644, and were coupled to beads
for pulldown assays. When incubated with CSF extracts, syn-
thetic nonphosphorylated RL tail peptides could bind Cdc27
as previously shown (Ohe et al., 2010) (Figure 5A). Notably,
however, both pS641- and pS644-peptides bound Cdc27
much (80%) less efficiently than the nonphosphorylated
peptides, and the doubly-phosphorylated peptides totally failed
to do so, similar to ultimate dipeptide RL/AA peptides; impor-
tantly, phosphatase treatment of these phospho-peptides could
restore their Cdc27-binding abilities (Figure 5A). Thus, the S641/
644-phosphorylated RL tail cannot bind the APC/C, with both
pS641 and pS644 largely contributing to this event. We then
asked whether a nonphosphorylated RL tail would be required
for full-length Emi2 to bind the APC/C. For this, we used
sEmi2(2A/MN8A), which is only weakly phosphorylated at
S641/644 (Figure 4C) and can bind the APC/C strongly (Fig-
ure 1C). When added to CSF extracts in an appropriate, excess
amount (for competition; Ohe et al., 2010), (bead-free) nonphos-
phorylated RL tail peptides, but not pS641-, pS644- or, particu-
larly, doubly-phosphorylated peptides, could efficiently inhibit
sEmi2(2A/MN8A) from binding the APC/C (Figure 5B). Thus,
a nonphosphorylated RL tail is required for sEmi2(2A/MN8A) to
strongly bind the APC/C.
Given these results, S641/644 phosphorylation could
contribute significantly to the inactivation of (full-length) Emi2.
Confirming this idea by mutagenizing S641/644 in sEmi2(2A)
was not practicable, however, because S641/644-substituted
Ala itself impairs APC/C binding of the RL tail and, hence,
cannot mimic nonphosphorylated S641/644 (Ohe et al., 2010)
(Figures 5D and 5F). We therefore asked whether any Ala substi-
tution(s) for S641/644-surrounding residues could decrease
S641 phosphorylation by Cdk1 (and hence also S644 phosphor-
ylation by CK1) and, thereby, could increase APC/C binding of
sEmi2(2A). All the Ala substitutions tested (G640A, Q643A,
S644A, and K645A), except S644A, significantly reduced S641
phosphorylation by Cdk1 in vitro (Figure 5C; see also Figure 4F).
Notably, however, only Q643A, which inhibited S641 phosphor-
ylation by Cdk1 by 35% (Figure 5C), increased the APC/C
binding of sEmi2(2A), with the other substitutions strongly inhib-
iting the binding (Figure 5D). This specific, positive effect of
Q643A on APC/C binding of sEmi2(2A) was most likely a result
of the decreased S641 phosphorylation rather than the Q643A
substitution itself, because the same substitution did not affect
APC/C binding of nonphosphorylated RL tail peptides (Fig-
ure 5E), as well as of sEmi2(MN8A) (a construct undergoing little
S641/644 phosphorylation; Figure S4) (Figure 5F). However, the
increase in APC/C binding of sEmi2(2A) by Q643A was only
2.5-fold (probably owing to the only 35% decrease of S641
phosphorylation; Figure 5C) (Figure 5D), and was similar to
that by the C-terminal (T545/551) C2A mutation (Figure 5G).
However, combined mutation (Q643A/C2A) caused a 6-fold(H) CSF extracts expressing (Myc3-tagged) sEmi2(2A) were treated with DMSO,
precipitation followed by immunoblotting.
(I) In vitro kinase assays of (Myc3-tagged) sEmi2(WT), performed as in (G) (CK1 b
(J) CSF extracts expressing both (Myc3-tagged) (s)Emi2 constructs and (Flag-ta
noblotting.
(K) The indicated peptides coupled to beads were incubated with CSF extracts
Developmenincrease in APC/C binding of sEmi2(2A), fairly close to the
(10-fold) APC/C-binding activity of sEmi2(2A/MN8A) (Fig-
ure 5G). Thus, considering the only partial decrease of S641
phosphorylation by Q643A, fully dephosphorylated S641 (and
S644), together with the C2A mutation, would fully restore the
APC/C-binding activity of sEmi2(2A). We confirmed that CK1
inhibition by D4476/IC261 (hence inhibition of S644 phosphory-
lation; Figure 4H) can increase APC/C binding of sEmi2(2A),
albeit substantially less greatly than Cdk1 inhibition by roscovi-
tine (which inhibits both S641 and S644 phosphorylation as
well as T545/551 phosphorylation; Figure 4E) (Figure 5H).
These results, together with the results with RL tail phospho-
peptides (Figures 5A and 5B), strongly suggest that S641/644
phosphorylation contributes largely to the inactivation of full-
length Emi2.
Mos/Rsk Recruits PP2A-B56b/ε to Emi2 and Thereby
Dephosphorylates the RL Tail
In PP2A holoenzymes, the regulatory B-type subunits, com-
prising at least three different subtypes (B55, B56, and PR70/
PR130), function as targeting and substrate-specificity factors
(Janssens et al., 2008). During CSF arrest, PP2A binds to Emi2
at the Mos/Rsk phosphorylation sites (S335/T336, or the sites
for the 2A mutation; Figure 1B), and likely dephosphorylates
both its N- (S213/T239/252/267) and C-terminal (T545/551)
Cdk1 sites to upregulate Emi2 stability and activity (J.Q. Wu
et al., 2007; Q. Wu et al., 2007). However, it is not known which
form of PP2A, in terms of the regulatory B-type subunits (Jans-
sens et al., 2008), binds to Emi2. We first addressed this issue
using GST-fused Emi2 protein (residues 301–400, containing
either WT S335/T336 or 2A). When incubated with CSF extracts
and GST-pulled down, GST-Emi2(301-400;WT), but not GST-
Emi2(301-400;2A), was associated with an endogenous PP2A
catalytic C subunit and ectopically expressed B56 isoforms
(especially b and ε), but not B55 or PR70/PR130 isoforms, of
the B-type subunit (Figures 6A–6C). Furthermore, by mass
spectrometry, b and ε isoforms of endogenous B56 protein
were found to bind to GST-Emi2(301-400;WT) but not GST-
Emi2(301-400;2A) (Figure S5), consistent with the results with
ectopically expressed B56 isoforms (Figure 6A). Thus, PP2A-
B56b/ε aremost likely themajor forms of PP2A that bind to Emi2.
We then askedwhether PP2A-B56 bound to S335/T336 would
indeed be required for the dephosphorylation of both the
N-terminal and C-terminal Cdk1 sites of Emi2 (as well as the
Cdk1/CK1 sites of the RL tail). For this, we compared the phos-
phorylation status of each Cdk1 or CK1 site between the WT
and the 2A Emi2 constructs. All four N-terminal Cdk1 sites
tested (S213/T239/252/267) were phosphorylated in sEmi2(2A),
but fairly less (45%–95%, depending on the sites) phos-
phorylated in sEmi2(WT) (Figure 6D). (T195, a Plk1 site, was
also less phosphorylated in sEmi2(WT); Figure S2A.) Interest-
ingly, the C-terminal Cdk1 site (T545) was even less (35%)300 mM D4476, or 300 mM IC261 for 30 min, and subjected to Myc immuno-
eing CK1d).
gged) CK1ε were subjected to Myc immunoprecipitation followed by immu-
expressing (Flag-tagged) CK1ε, pulled down, and immunoblotted.
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Figure 5. Inactivation of Emi2 by S641/644 Phosphorylation
(A) The indicated RL tail peptides coupled to beadswere untreated or treatedwith l phosphatase, incubatedwith CSF extracts, pulled down, and immunoblotted.
RL/AA peptides are negative control for APC/C binding (Ohe et al., 2010).
(B) CSF extracts expressing (Myc3-tagged) sEmi2(2A/MN8A) were incubated with the indicated RL tail peptides (0.3 mM) for 20 min, and subjected to immu-
noprecipitation/immunoblotting.
(C) The indicated RL tail peptides (fused to GST) were subjected to in vitro kinase assays using [g-32P]ATP and cyclin B1-Cdk1.
(D) The indicated (Myc3-tagged) sEmi2 constructs expressed in CSF extracts were immunoprecipitated, immunoblotted, and analyzed as in Figure 1C (mean ±
SD, n = 4).
(E) Pulldown assays of RL tail peptides, performed as in (A).
(F and G) The indicated (Myc3-tagged) sEmi2 constructs were expressed in CSF extracts, and analyzed as in (D) (mean ± SD, n = 3).
(H) CSF extracts expressing (Myc3-tagged) sEmi2(2A) were treated with control DMSO, 300 mM D4476, 300 mM IC261, or 300 mM roscovitine for 30 min, and
subjected to immunoprecipitation/immunoblotting.
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Regulation of Emi2 Stability and Activityphosphorylated in sEmi2(WT) than in sEmi2(2A) (Figure 6D).
Notably, similarly or even more reduced phosphorylation was
observed with the Cdk1 site S641 (30%) and the CK1 site
S644 (10%) of the RL tail in sEmi2(WT), as compared with the
phosphorylation in sEmi2(2A) (Figure 6D). Importantly, essentially
the same differences in phosphorylation of the respective
Cdk1 and CK1 sites were observed between sEmi2(WT) and
sEmi2(S342/344A), another Emi2 mutant incapable of binding
PP2A (J.Q. Wu et al., 2007) (Figure 6D). Thus, unexpectedly, in
sEmi2(WT), recruited PP2A-B56 seems to somehow dephos-514 Developmental Cell 21, 506–519, September 13, 2011 ª2011 Elsphorylate the functional C-terminal Cdk1/CK1 sites significantly
more strongly than the regulatory N-terminal Cdk1 sites.
The only partial dephosphorylation of the N-terminal Cdk1
sites in sEmi2(WT), which would also cause a partial dephos-
phorylation of the C-terminal Cdk1/CK1 sites (due to the partial
decrease in N-terminal Cdk1 binding; Figure 2A), cannot by
itself explain the significantly greater dephosphorylation of the
C-terminal Cdk1/CK1 sites. We therefore asked whether re-
cruited PP2A-B56 could directly dephosphorylate the C-terminal
Cdk1/CK1 sites (in addition to the N-terminal Cdk1 sites). Forevier Inc.
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Figure 6. Dephosphorylation of the RL Tail by Recruited PP2A-B56
(A–C) GST-Emi2(301-400;WT or 2A) protein was incubated with CSF extracts expressing (Flag-tagged) PP2A B56 isoforms (A), B55 isoforms (B), or PR70/PR130
isoforms (C), GST-pulled down, and immunoblotted.
(D and E) (Myc3-tagged) sEmi2 constructs were expressed in CSF extracts, immunoprecipitated, and analyzed as in Figure 4A (mean ± SD, n = 5 for D and n = 3
for E).
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mutation-containing Emi2 constructs (to eliminate the indirect
effect of N-terminal dephosphorylation on C-terminal dephos-
phorylation). As shown in Figure 6E, phosphorylations of T545,
S641, and S644 in sEmi2(MN8A) (a construct used in Figure 5F
and Figure S4) were all much (80%) weaker even than those
in sEmi2(2A/MN8A) (which itself has much less C-terminal phos-
phorylation than sEmi2(2A); Figures 4A and 4C). Because
sEmi2(MN8A) but not sEmi2(2A/MN8A) can bind PP2A-B56,
these results indicate that PP2A-B56 can directly dephosphory-
late the C-terminal Cdk1/CK1 sites (although, in these cases, the
observed phosphorylations would be performed by Emi2-
unbound, free Cdk1/CK1). Thus, PP2A-B56 seems to strongly
dephosphorylate the C-terminal sites by both direct and indirect
actions.
Retrospectively, unlike sEmi2(2A/MN8A), sEmi2(WT) showed,
albeit to lesser extents than sEmi2(2A), phosphatase-sensitive
gel-mobility shifts (Figure 1C), N-terminal binding of Cdk1/Plk1Developmen(Figure 2A), and T195 phosphorylation and instability (for
Emi2(WT)) (Figure 3D and Figure S2A), apparently reflecting
its moderate phosphorylation at the N-terminal Cdk1 sites (Fig-
ure 6D). However, sEmi2(WT) did show high APC/C-binding/
inhibitory activities close to those of sEmi2(2A/MN8A) (Fig-
ures 1C and 1D), most certainly due to its only weak phosphor-
ylation at the C-terminal Cdk1/CK1 sites (Figure 6D), similar
to sEmi2(2A/MN8A) (Figures 4A and 4C). sEmi2(WT), unlike
sEmi2(2A/MN8A), however, still binds both Cdk1 and CK1 (albeit
moderately). In WT Emi2, therefore, active and continuous
dephosphorylation of the C-terminal Cdk1/CK1 sites by re-
cruited PP2A-B56 would be indispensable to maintain the high
Emi2 activity.
DISCUSSION
Our results clarify precise, dynamic control mechanisms of Emi2
stability and activity in Meta-II arrest of Xenopus eggs, and,tal Cell 21, 506–519, September 13, 2011 ª2011 Elsevier Inc. 515
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Figure 7. Models for the Dynamic Regulation of Emi2 Stability and
Activity during Meta-II Arrest and for the Maintenance of Meta-II
Arrest
(A) Cdk1 first phosphorylates Emi2 on N-terminal Cdk1 sites (S43T267), to
the partially overlapping sites of which Cdk1, Plk1, and CK1d/ε bind. Plk1 then
phosphorylates T170/195 of Emi2 to create its own (PB-dependent) stronger
rebinding sites, thereby further phosphorylating the SCFb-TrCP-recognizing
DSG/DSAmotifs to destabilize Emi2. On the other hand, Cdk1 phosphorylates
C-terminal T545/551 and S641 of the RL tail, the latter phosphorylation
enabling phosphorylation of S644 by CK1d/ε; these phosphorylations prevent
Emi2 from binding and inhibiting the APC/C. Upon S335/T336 phosphorylation
by Rsk, however, Emi2 recruits PP2A-B56b/ε, which continuously antagonize
the inhibitory phosphorylations by Cdk1/Plk1/CK1, particularly at the RL tail
(and T545/551), thereby keeping upregulating Emi2 activity and stability. In the
figure, the blue and red lines show the inactivation and activation pathways of
Emi2, respectively.
(B) Meta-II arrest is robustly maintained by both PP2A-B56b/ε activity and
inhibition of PP2A-B55d. For details, see text.
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robustly maintained (Figure 7). In addition, our data seem to
suggest a general role for Cdk1 substrate phosphorylationmotifs
in M phase regulation.
Inactivation of Emi2 at M Phase by N-Terminal Cdk1
Phosphorylation
Mos/Rsk-phosphorylated Emi2 actively binds and inhibits the
APC/C, thereby causing Meta-II arrest in Xenopus eggs. In
contrast to the previous proposal (J.Q. Wu et al., 2007), our
results show that multiple N-terminal phosphorylations by
Cdk1 not only destabilize but also inactivate Emi2. Interestingly,
in early embryos (which lack the Mos-MAPK pathway but not
Emi2; see Introduction), endogenous Emi2 undergoes Cdk1-
dependent hyperphosphorylation at M phase and is largely inac-
tive (Liu et al., 2006; Nishiyama et al., 2007), but ectopically ex-
pressed Emi2 lacking the N-terminal Cdk1 sites is highly active
and can cause metaphase arrest (see Figure 1E). Thus, most
likely, Emi2 N-terminally phosphorylated at M phase is an inacti-516 Developmental Cell 21, 506–519, September 13, 2011 ª2011 Elsvated form of Emi2, and the Mos-MAPK pathway functions to
prevent the M phase inactivation of Emi2 specifically in meiosis.
Dynamic Regulation of Emi2 by Emi2-Bound Multiple
Kinases and PP2A
Surprisingly, our results show that cyclin B1-Cdk1 itself, Plk1,
and CK1d/ε bind to the partially overlapping N-terminal Cdk1
sites of Emi2, resulting in Emi2 inhibition (Figure 7A). Plk1, after
rebinding to other sites by self-priming phosphorylation, phos-
phorylates the DSG/DSA degradation motifs and partially desta-
bilizes Emi2, whereas Cdk1 and CK1 sequentially phosphorylate
the C-terminal RL tail and thereby inhibit Emi2 from binding
the APC/C. Cdk1 also phosphorylates other C-terminal sites
(T545/551). This phosphorylation also contributes to Emi2 inac-
tivation (consistent with previous reports; Hansen et al., 2007;
Q. Wu et al., 2007), but, apparently, significantly less largely
than the phosphorylation of the RL tail. T545/551 residues are
located between the D-box and the ZBR, which are both partially
required for APC/C binding of Emi2, whereas the RL tail is
absolutely required (Ohe et al., 2010). Thus, Emi2 seems to be
inactivated principally by phosphorylation of the RL tail by
Emi2-bound Cdk1 and CK1.
Our results also show that PP2A-B56b/ε bind to Rsk-phos-
phorylated Emi2 and tip the balance of Emi2-bound kinase and
phosphatase activities in favor of dephosphorylation, thereby
upregulating Emi2 activity and stability (Figure 7A). PP2A-
B56b/ε dephosphorylate the N-terminal Cdk1 sites only partially,
allowing Cdk1/CK1 to still bind to Emi2 (albeit moderately).
However, via their direct action, PP2A-B56b/ε keep strongly
dephosphorylating the C-terminal Cdk1/CK1 phosphorylation
sites, thereby maintaining Emi2 activity high. The partial dephos-
phorylation of the N-terminal Cdk1 sites by PP2A-B56b/εmay be
due to the sustained, high, Emi2-unbound free Cdk1 activity
(which is responsible for the phosphorylation of the N-terminal
sites), as well as to the (protective) binding of Cdk1/Plk1/CK1.
This feature of Emi2 regulation is probably important, however,
because N-terminally full-dephosphorylated (hence fully acti-
vated) Emi2 causes premature Meta-I arrest in oocytes (Fig-
ure S6). Thus, Emi2 activity properly upregulated by the Mos-
MAPK pathway is essential for the normal meiotic cell cycle in
oocytes. Emi2 phosphorylation sites for Cdk1, Plk1, CK1, and
Rsk are well-conserved in vertebrates. Therefore, the dynamic
regulation of Emi2 activity and stability we uncovered here may
be general.
Binding of Cyclin B1-Cdk1, Plk1, and CK1d/ε to Cdk1
Phosphorylation Sites
Cyclin B-Cdk1 has been shown to bind to the Cdk1 phosphory-
lation sites (S/TP) in Cdc6 and separase (Gorr et al., 2005;
Mimura et al., 2004). In these cases, Cdk1 strongly binds to
the Cdk1 sites through its cyclin B partner, and its kinase activity
(as well as the activity of Cdc6 and separase) is inhibited by
the binding (Calzada et al., 2001; Gorr et al., 2005; Mimura
et al., 2004). As shown here, cyclin B1-Cdk1 also binds
specifically to the N-terminal Cdk1 sites of Emi2. However, this
binding, unlike the case with Cdc6 or separase (Gorr et al.,
2005; Mimura et al., 2004), is not so strong (as it can be readily
loosened by treatment with 0.4 M NaCl), nor mediated by cyclin
B1 alone (which cannot bind to Emi2 in vitro), nor, as expected,evier Inc.
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can be detected in vitro after Emi2 immunoprecipitation) (our
unpublished data). Thus, Cdk1 binding to the Emi2 Cdk1 sites
seems to be different, both mechanistically and functionally,
from those to the Cdc6/separase Cdk1 sites, although, formally,
it could be mediated by Cks1, a small subunit of the cyclin B1-
Cdk1 complex (Patra et al., 1999). Functionally, Cdk1 bound
to the Emi2 N-terminal Cdk1 (consensus) sites phosphorylates
the Cdk1 nonconsensus site (S641) of the RL tail (as well as
the C-terminal consensus sites, or T545/551). Interestingly, in
budding-yeast Swe1 and Boil, Cdk1-catalyzed phosphorylation
of Cdk1 nonconsensus sites occurs and requires phosphoryla-
tion of Cdk1 consensus sites (Harvey et al., 2005; McCusker
et al., 2007). Therefore, in these cases as well, Cdk1 might
bind to the Cdk1 consensus sites and phosphorylate other sites,
particularly Cdk1 nonconsensus sites. Locally concentrated
Cdk1 could phosphorylate even nonconsensus sites, although
S641 of the Emi2 RL tail is a good substrate for Cdk1 in vitro.
Plk1 plays multiple roles during mitosis, and Cdk1 creates
binding sites for Plk1 in many mitotic proteins (Park et al.,
2010). In these cases, Cdk1 phosphorylates a Ser or Thr residue
(S/T) in the SS/TP motifs, which contain both the Cdk1
consensus motif (S/TP) and the Plk1-PB-binding motif (SS/T;
Elia et al., 2003). In a few other proteins, however, Plk1 itself
phosphorylates the PB-binding SS/T motifs and primes its own
binding to the proteins (Kang et al., 2006; Neef et al., 2007). In
this case, it is not knownwhether the SS/Tmotif phosphorylation
by Plk1 requires a prior Plk1 binding to the protein. As shown
here, in Emi2, however, Plk1 first binds to the N-terminal, simple
Cdk1 motifs (S/TP, not preceded by Ser) and then phosphory-
lates the PB-binding ST motifs (T170/195) for its own rebinding.
However, Plk1 binding to the Cdk1motifs is substantially weaker
than that to the PB-binding motifs. Thus, in Emi2, the low-affinity
Plk1-Cdk1 motif interactions would be to facilitate subsequent
phosphorylation and binding of the PB-binding motifs by Plk1.
Similar Plk1-Cdk1 motif interactions could have occurred in
some Plk1 substrates so far described, but might have been
overlooked because of their weak nature.
CK1d/ε regulate multiple cellular processes, including the
circadian rhythm, and phosphorylate many substrates at the
prephosphorylated pS/pT-X-X-S/T motifs (Gross and Anderson,
1998). However, it is not well understood how CK1d/ε recognize
substrates. Our results show that CK1d/ε bind to the N-terminal
Cdk1 sites of Emi2, and phosphorylate S644 of the RL tail after
the priming S641-phosphorylation by Cdk1. During mitosis,
CK1d/ε are enriched at the spindles and their inhibition induces
mitotic defects, suggesting a role in mitotic progression (Sto¨ter
et al., 2005). Thus, given our results, CK1d/ε could also recognize
and phosphorylate at least some mitotic substrates in a Cdk1-
dependent manner.
Role for PP2A in Maintaining Meta-II Arrest
The PP2A holoenzyme is involved in nearly all cellular processes,
including the cell cycle (Millward et al., 1999). The underlying
basis for this broad functional diversity is the complex structure
and regulation of the PP2A holoenzyme (Janssens et al., 2008).
Interestingly, recent studies indicate that PP2A-B55d dephos-
phorylates Cdk1 substrates upon exit from mitosis, but is inacti-
vated by Greatwall kinase during M phase (Castilho et al., 2009;DevelopmenMochida et al., 2010). Inhibition of PP2A-B55d therefore contrib-
utes to themaintenance of Cdk1-driven phosphorylations during
M phase. Paradoxically, in Xenopus (and mouse) eggs and CSF
extracts, however, PP2A activity is essential for the maintenance
of M phase, or for Meta-II arrest (Chang et al., 2011; Lorca et al.,
1991; Q. Wu et al., 2007). Interestingly, such PP2A activity is
associated with Rsk-phosphorylated Emi2 (J.Q. Wu et al.,
2007), and here we identify the responsible PP2A holoenzyme
as PP2A-B56b/ε. Emi2-bound PP2A-B56b/ε locally antagonize
inhibitory Cdk1/Plk1/CK1d/ε phosphorylations on Emi2, thereby
upregulating Emi2 and hence inhibiting the APC/C. In CSF
extracts, APC/C inhibition by Emi2 globally maintains cyclin B-
Cdk1 activity (Schmidt et al., 2005), whereas PP2A-B55d inhibi-
tion by Greatwall globally maintains Cdk1 phosphorylations of M
phase substrates (Vigneron et al., 2009). Thus, Meta-II arrest is
robustly maintained by both PP2A-B56b/ε activity and inhibition
of PP2A-B55d (Figure 7B). It remains to be elucidated whether
PP2A-B56b/ε undergo any specific regulations, such as an upre-
gulation of their phosphatase activity byMos/Rsk, duringMeta-II
arrest.Possible Implications for S/TP Motifs in M Phase
Regulation
Cyclin B-Cdk1 is themaster regulator ofMphase of the cell cycle
(Enserink and Kolodner, 2010). Therefore, our findings that
multiple Cdk1 consensus motifs (S/TP), clustered in the
N-terminal region of Emi2, can bind multiple functional kinases,
such as cyclin B1-Cdk1 itself, Plk1, and CK1d/ε, are significant.
Indeed, numerous mitotic proteins, including Wee1 and Cdc25,
also have multiple S/TP motifs that are clustered in their disor-
dered regions (Holt et al., 2009; Moses et al., 2007), and they
are often targeted by other mitotic kinases, such as Plk1 and
Aurora-A (Dephoure et al., 2008; Lowery et al., 2007). Given
our results, phosphorylation of such multiple S/TP motifs could
function in considerable cases to create interacting sites for
multiple mitotic kinases, including Cdk1 itself. In this case, the
presence of multiple S/TPmotifs in the flexible disordered region
of one such mitotic protein could give the protein a favorable
opportunity to capture multiple kinases. On this occasion,
however, potentially low-affinity kinase-S/TP motif interactions
in that protein, which are likely the cases in Emi2, could allow
the kinases to interact further with many other S/TP-containing
mitotic proteins. If these were the cases, the implications would
be that multiple S/TPmotifs in mitotic proteins function to ensure
common substrate recognition, and hence concerted M phase
regulation, by the multiple mitotic kinases. If so, this could be
the major reason why Cdk1 can operate as the master regulator
of M phase. In our study, not all (mitotic) kinases tested bind
to Emi2, nor do all Emi2 N-terminal S/TP sites tested equally
bind cyclin B1-Cdk1, Plk1, or CK1. Therefore, more precisely
analyzing the structural bases of the kinase-Emi2 S/TP motif
interactions could help us generalize kinase-S/TP motif interac-
tions in mitotic proteins.EXPERIMENTAL PROCEDURES
Biochemical reagents, cDNAs, in vitro transcription/translation, antibodies,
immunoblotting, in vitro kinase assays (including GST-Emi2 peptide fusion
proteins), and pulldown assays are described in the Supplemental Information.tal Cell 21, 506–519, September 13, 2011 ª2011 Elsevier Inc. 517
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CSF extracts were prepared from unfertilized Xenopus eggs and, in some
cases, treated with 500 mM CaCl2 to induce a release from CSF arrest, as
described previously (Ohe et al., 2010).Immunoprecipitation
Myc3-tagged Emi2 constructs were ectopically expressed in CSF extracts by
incubating 1–3 mg of their mRNAs with 50 ml of CSF extracts for 1.5 hr at 23C,
and they were usually subjected to immunoprecipitation followed by immuno-
blotting. For this, typically 50 ml of CSF extracts expressing Myc3-Emi2
constructs were diluted with 200 ml of an immunoprecipitation buffer (IPB:
20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM 6DAP, 10 mM EDTA, 5 mM
NaF, 1 mM Na3VO4, 1 mM okadaic acid, 20 mM leupeptin, 2 mM pepstatin,
10 mg/ml aprotinin, 400 mM PMSF, 1 mM DTT), added with 15 ml of a slurry
of beads coupled with anti-Myc antibody (ab1253, Abcam), incubated (with
constant rotation) for 30 min at 23C, and then washed twice with IPB (plus
0.2% Tween 20) and twice with IPB at 4C. The immunoprecipitates, equiva-
lent to 15–30 ml of CSF extracts, were treated or not treated with l phospha-
tase before immunoblotting, as described previously (Ohe et al., 2007).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at doi:10.1016/
j.devcel.2011.06.029.ACKNOWLEDGMENTS
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